Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:18:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Major change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.
    Difference
    3%
    Check dated 2025-10-05T10:07:14.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    - Version label updated from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:12:51.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; Back to Top link removed. No substantive changes to core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-13T17:33:10.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:50:24.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional medical terms related to ocular melanoma and various proteins, while some previous terms and locations have been removed.
    Difference
    3%
    Check dated 2025-08-30T11:37:21.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.